Translational Medicine Postdoctoral Fellowship supports postdoctoral researchers in collaborative training that translates laboratory discoveries into clinical approaches to improve patient care.
Funder: PhRMA Foundation
Due Dates: October 30, 2026, noon ET (Second-cycle LOI) | November 6, 2026 (First-cycle full application) | March 2027 (Second-cycle full application; exact date provided upon invitation)
Funding Amounts: $60,000 per year in stipend support for 12, 18, or 24 months
Summary: Supports collaborative postdoctoral training that translates laboratory discoveries into clinical approaches addressing unmet needs and improving patient care.
Key Information: Second-cycle applicants must have a qualifying doctorate conferred on or after January 1, 2024, and at least two first-author publications.
The PhRMA Foundation’s Translational Medicine Postdoctoral Fellowship supports multidisciplinary, collaborative research training at accredited U.S. universities. The program connects laboratory discoveries with clinical practice to improve disease prevention, diagnosis, and treatment, while bringing lessons from the clinic back to the laboratory. It prioritizes unmet clinical needs and new diagnostic, therapeutic, and computational approaches that improve patient care.
Research may address innovative diagnostics and therapies in human-relevant models, precision medicine, clinical endpoint validation, or experimental and computational methods that reduce animal testing. Other areas include biologically validated modeling and simulation, translational pharmacokinetics and pharmacodynamics, and target or biomarker validation using human data or human-derived systems. Proposals must connect a therapeutically relevant hypothesis with clinical needs and appropriate human-relevant validation.